- NCIt
- C39784
Loading cancer entity…
Loading cancer entity…
Clinical trials
84 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07801560 | CyberKnife Radiotherapy for the Treatment of Schwannomas(Schwannomas) | completed | — | 200 | Hartmann Oncology Radiotherapy Group, FranceOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT04283669 | Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas(NF110) | completed | Phase 2 | 12 | University of Alabama at BirminghamOTHER |
| 1 |
| Mar 13, 2026 |
| clinicaltrials |
| NCT05786144 | Vestibular Schwannoma Organoids | completed | — | 100 | Maastricht Radiation OncologyOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT06322342 | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent | completed | Phase 2 | 18 | Reveal Pharmaceuticals Inc.INDUSTRY | 1 | Dec 26, 2025 | clinicaltrials |
| NCT07305285 | Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma | completed | N/A | 160 | West China HospitalOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT04057976 | Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas | completed | N/A | 38 | King's College Hospital NHS TrustOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT02249572 | Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.(V-REX) | completed | N/A | 100 | Haukeland University HospitalOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT04241679 | Auditory Nerve Test System During Vestibular Schwannoma Resection(ANTS) | completed | N/A | 10 | Washington University School of MedicineOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT01938677 | Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study | completed | N/A | 67 | Karolinska InstitutetOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT04351373 | Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560 | completed | Phase 2 | 12 | Mayo ClinicOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT03581331 | Consequence of Unilateral Vestibular Loss on Visual Abilities(SVorthoptie) | completed | N/A | 20 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT03958006 | Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma | completed | N/A | 6 | Henry Ford Health SystemOTHER | 1 | Apr 20, 2023 | clinicaltrials |
| NCT03666507 | Vegetative Monitoring During Brainstem-associated Surgery | completed | — | 103 | University Hospital TuebingenOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT04658836 | Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF | completed | Phase 1 | 21 | Medical University of ViennaOTHER | 1 | Aug 24, 2022 | clinicaltrials |
| NCT01129687 | Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy | completed | — | 157 | Stanford UniversityOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT02948790 | Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma(NeuriStim) | completed | N/A | 17 | Oticon MedicalINDUSTRY | 1 | Oct 20, 2021 | clinicaltrials |
| NCT02934256 | Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors(Icotinib) | completed | Phase 2 | 10 | Li PengOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT01125046 | Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas | completed | Phase 2 | 50 | Northwestern UniversityOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT00863122 | Concentration and Activity of Lapatinib in Vestibular Schwannomas | completed | Early Phase 1 | 26 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 12, 2021 | clinicaltrials |
| NCT02309099 | Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach | completed | N/A | 10 | University of North Carolina, Chapel HillOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT01207687 | Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) | completed | Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Aug 27, 2018 | clinicaltrials |
| NCT03638310 | Role of Psychiatric Profile in Prehabituated Patients After Vestibular Schwannoma Surgery | completed | N/A | 37 | Charles University, Czech RepublicOTHER | 1 | Aug 20, 2018 | clinicaltrials |
| NCT03210285 | WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data(NF2) | completed | — | 70 | University Hospital TuebingenOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT02104323 | Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors(Endostatin) | completed | Phase 2 | 20 | Beijing Tiantan HospitalOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT02963896 | Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma(ITG) | completed | N/A | 20 | University Hospital, MotolOTHER | 0 | Nov 15, 2016 | clinicaltrials |
| NCT00973739 | Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors | completed | Phase 2 | 21 | NYU Langone HealthOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT01119599 | RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma | completed | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | Sep 29, 2015 | clinicaltrials |
| NCT00411216 | Recovery of Visual Acuity in People With Vestibular Deficits | completed | N/A | 23 | Emory UniversityOTHER | 1 | Aug 7, 2015 | clinicaltrials |
Data updated 20 days agoSource updated Sep 9, 2026source: clinicaltrials